92.9 F
San Fernando
Friday, Dec 1, 2023

GlaxoSmithKline Renews License With Simulations Plus

Pharmaceutical software firm Simulations Plus Inc. announced that GlaxoSmithKline has renewed its global multi-year license for Simulations Plus software and has added a new site at its Parsippany, N.J. location. “We appreciate the continued confidence GSK has shown in Simulations Plus over the years, as well as suggestions for improvement they have provided that are now standard features in our programs,” said Walt Woltosz, chairman and chief executive officer of Lancaster-based Simulations Plus. “This is a time of growing use of simulation and modeling tools in pharmaceutical research, and GSK has been one of the companies at the forefront. We look forward to continuing the excellent relationships we have with GSK scientists worldwide.”

Featured Articles

Related Articles